Genetic testing has potential benefits whether the results are positive or negative for a gene mutation. Test results can provide a sense of relief from uncertainty and help people make informed decisions about managing their health care. There are several use for genetic testing:
– Diagnostic testing: it is used to identify or confirm the diagnosis of a disease or condition in a person or a family. It is helpful in determining the course of a disease and the choice of treatment.
– Predictive genetic testing: it determines the chances that a healthy individual with or without a family history of a certain disease might develop that disease.
– Presymptomatic genetic testing: it is used to determine whether persons who have a family history of a disease, but no current symptoms, have the gene alterations associated with the disease.
– Carrier testing: it is performed to determine whether a person carries one copy of an altered gene for a particular disease.
a- Background Hypertrophic cardiomyopathy (HCM, OMIM#192600) is a well-known primary disease of the myocardium. HCM is defined by unexplained ventricular hypertrophy with preferential hypertrophy of the septum and anterior left ventricular wall in the absence of a detectable cause. This disorder has a prevalence within the general population of one in 500, or 0.2%. It
We now offer acute blood genetic tests to prevent and manage any risk of illnesses linked to your personal indications and family history. Step 1: Pre-test consultation with our genetic counsellor who will assess the need for a specific genetic analysis upon clinical indication and family history. Step 2: Our specialized physician makes a proposition
a- Background Epilepsy is a common neurological disorder characterized by recurrent seizures. It has an estimated prevalence of about 0.08% and a lifetime cumulative incidence of about 3%. Approximately 60% of epilepsy cases have no cause other than a genetic predisposition, while the rest are due to a major acquired cause. However, the probability of
a- Background Colorectal cancer (CRC) affects 1 in 20 people during their lifetime. An estimated 25% of all CRC cases present a familial clustering of the disease suggesting a contribution of genetic factors among other risk factors, while approximately 5% of all CRC cases are purely hereditary. Hereditary non-polyposis colorectal cancer, also known as Lynch